摘要
各种肾性骨病的发生率已发生变化。目前血PTH和ALP测定仍然是诊断肾性骨病时最常用的无创性检查,最新的PTH测定法(S-IRMA法)和骨特异的碱性磷酸酶测定方法(BAP)将会进一步改进对甲状旁腺功能亢进和肾性骨病的诊断。骨活检仍是诊断的金标准。本文从肾性骨营养不良主要类型、生化指标和骨活检的意义及肾性骨病的治疗等方面进行阐述。肾性骨病治疗指征要严格掌握,既要防止延误治疗,也要避免过度治疗。
incidence rates of different kinds of renal osteopathy have changed. Currently blood PTH and ALP testing are still the most common non-traumatic examinations. The newest PTH testing （ S-IRMA ） and BAP will help to approve the diagnosis of hyperparathyroidism and renal osteopathy further. Bone biopsy is still the golden criteria. This article expatiated the renal osteopathy from main types of renal osteodystrophy, significance of biochemical index and bone biopsy and treatment of renal osteopathy. Treatment indication of renal osteopathy should be mastered strictly for avoiding delayed or excessive treatment.
出处
《实用医院临床杂志》
2006年第4期2-5,共4页
Practical Journal of Clinical Medicine
关键词
肾性骨病
检测方法
治疗方法
renal osteopathy
testing methods
treatment
